Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints first woman to the board

Karin Louise Dorrepaal will serve as an independent board member

Spanish pharmaceutical company Almirall has picked Karin Louise Dorrepaal to sit on its board of directors as an independent board member.

She is the first woman to join the Barcelona-based company's ten member board and has gained extensive international experience in the pharmaceutical sector during her 25 year career.

This includes six years serving as director of global business unit diagnostic imaging and supply chain and procurement at Bayer Pharma and sitting on the board of Schering for two years.

Dorrepaal currently holds non-executive positions in healthcare sector and consultancy companies.

Earlier this month, she was appointed to the supervisory board of German specialty pharma company Paion, where she replaced Grünenthal chief executive Harald Stock. 

Dorrepaal's appointment to the Almirall board will take effect from January 1, 2013, and will be ratified at the company's next annual general meeting.

23rd November 2012

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics